Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Accuracy of liquid-based cytology in diagnosis of high-grade squamous cervical intraepithelial neoplasia].

Li M, Mei P, Luo DL, Wang XB, Liu YH.

Zhonghua Bing Li Xue Za Zhi. 2012 Apr;41(4):265-8. doi: 10.3760/cma.j.issn.0529-5807.2012.04.011. Chinese.

PMID:
22800524
2.

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.

Acta Cytol. 2012;56(5):506-14. doi: 10.1159/000338979. Epub 2012 Sep 27.

PMID:
23075891
3.

p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.

Zhang G, Yang B, Abdul-Karim FW.

Int J Gynecol Pathol. 2015 Mar;34(2):180-6. doi: 10.1097/PGP.0000000000000112.

PMID:
25675189
5.

Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.

Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N.

Int J Cancer. 2013 Jan 15;132(2):327-34. doi: 10.1002/ijc.27680. Epub 2012 Jul 3.

6.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
7.

Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.

Pajtler M, Milicić-Juhas V, Milojković M, Topolovec Z, Curzik D, Mihaljević I.

Coll Antropol. 2010 Mar;34(1):81-6.

PMID:
20432737
8.

[Application of high-risk human papillomavirus testing in women with abnormal cytology].

Ou H, Bian ML, Zhang XY, Chen QY, Li M, Chen Y, Liu J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):608-11. Chinese.

9.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.

Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.

PMID:
21865084
10.

[Pregnancy related cervical cytological changes and clinical management].

Ma L, Bian ML, Liu J, Wang XH, Pang CH, Chen Y.

Zhonghua Fu Chan Ke Za Zhi. 2011 Feb;46(2):84-7. Chinese.

PMID:
21426763
11.

Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.

Gao FF, Austin RM, Zhao C.

Cancer Cytopathol. 2011 Dec 25;119(6):377-86. doi: 10.1002/cncy.20176. Epub 2011 Jul 19.

12.

A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.

Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong SD, Sun YT.

Acta Cytol. 2003 Jan-Feb;47(1):45-50.

PMID:
12585030
13.

[The usefulness of p16INK4a in cytological screening of cervical carcinoma].

Li M, Cao J, Wang NP, Li LY, Li L, Qiao YL, Pan QJ.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):674-7. Chinese.

PMID:
17274373
14.

Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.

Pan QJ, Hu SY, Zhang X, Ci PW, Zhang WH, Guo HQ, Cao J, Zhao FH, Lytwyn A, Qiao YL.

Cancer Cytopathol. 2013 Sep;121(9):473-82. doi: 10.1002/cncy.21297. Epub 2013 Apr 23.

15.

Cervical squamous intraepithelial lesions and associated cervical infections in an HIV-positive population in Rural Mpumalanga, South Africa.

Swanepoel PJ, Michelow P, Du Plessis R, Proudfoot IG, Tarr GA, Bockel SL, Swanepoel CJ.

Cytopathology. 2013 Aug;24(4):264-71. doi: 10.1111/j.1365-2303.2012.00998.x. Epub 2012 Jul 23.

PMID:
22817687
16.

Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.

Zhou F, Pulinthanathu R, Elgert P, Cangiarella J, Simsir A.

Diagn Cytopathol. 2015 May;43(5):381-7. doi: 10.1002/dc.23243. Epub 2014 Dec 26.

PMID:
25546355
18.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
19.

Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.

Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.

Gynecol Oncol. 2014 May;133(2):172-9. doi: 10.1016/j.ygyno.2014.03.008. Epub 2014 Mar 11.

PMID:
24631450
20.

Supplemental Content

Support Center